Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | Apr 4, 2023 | by Trust | |
Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | Apr 4, 2023 | Direct | |
Apollo Endosurgery, Inc. | Director | Stock Option (Right to Buy) | 0 | $8.86 | Apr 4, 2023 | Direct | |
REATA PHARMACEUTICALS INC | Director | Class A common stock | 0 | $172.03 | Sep 26, 2023 | Direct | |
REATA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | Sep 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RETA | REATA PHARMACEUTICALS INC | Sep 26, 2023 | 12 | $0 | 4 | Sep 26, 2023 | Director |
RETA | REATA PHARMACEUTICALS INC | Jul 28, 2023 | 5 | -$690K | 4 | Aug 1, 2023 | Director |
RETA | REATA PHARMACEUTICALS INC | Jun 7, 2023 | 4 | $177K | 4 | Jun 9, 2023 | Director |
APEN | Apollo Endosurgery, Inc. | Apr 4, 2023 | 9 | $0 | 4 | Apr 4, 2023 | Director |
APEN | Apollo Endosurgery, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
RETA | REATA PHARMACEUTICALS INC | Jun 8, 2022 | 4 | $155K | 4 | Jun 9, 2022 | Director |
RETA | REATA PHARMACEUTICALS INC | Jan 3, 2022 | 2 | $3.21K | 4 | Jan 5, 2022 | Director |
APEN | Apollo Endosurgery, Inc. | Jun 17, 2021 | 2 | $46.7K | 4 | Jun 21, 2021 | Director |
RETA | REATA PHARMACEUTICALS INC | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |